Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ADAP similar filings
- 4 Nov 21 Adaptimmune Reports Third Quarter Financial Results and Business Update
- 13 Sep 21 Other Events
- 7 Sep 21 Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
- 20 Aug 21 Entry into a Material Definitive Agreement
- 13 Aug 21 Entry into a Material Definitive Agreement
- 9 Aug 21 Adaptimmune Reports Second Quarter Financial Results and Business Update
- 19 May 21 Two Complete Responses and Response Rate of 41% for People with Synovial Sarcoma Reported at ASCO in Adaptimmune’s Phase 2 SPEARHEAD-1 Trial
Filing view
External links